ITC begins clinical trial of Covid19 nasal spray. Questions that one should ask.

The Company has confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated the clinical trials.

Key points to note –

  • The product would be helpful in preventing infection and transmission of COVID-19.
  • It has been developed by scientists at ITC Life Sciences and Technology Centre (LSTC). The same team during initial Covid outbreak was key behind the launch of ITC’s hygiene products.
  • Post approval, nasal spray may get launched under the Savlon brand.
  • Timelines for approval and launch are currently unclear.

Though market was excited post the announcement, personally I am more keen to understand ITC’s strategy around the overall segment.

  • What is the thought process behind this segment?
  • What are ITC’s budget spend targets towards this business?
  • Which other products is LSTC developing currently and what can be expected in the foreseeable future?
  • What is the marketing strategy around these products? Would it be over the counter or routed through medical prescriptions? Both are very-2 different and need a completely different strategy.
  • and many more…

One off opportunistic product launches don’t excite me as such.

Companies -
Notify of
1 Comment
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x